Rivkin Radler’s Marc Ullman was quoted in the NutraIngredients-USA article, “COVID-19 and legal chaos dent CBD market – but Congress and a stronger economy offer hope.” The article discusses the state of the CBD market amid the COVID-19 pandemic and legal battles.
“The market is a mess and the FDA doesn’t want to clean up the mess it created,” Marc said. “FDA has put themselves in a box where they can’t do anything to enforce quality enforcement because they have stated CBD is a drug.“